HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia.

Abstract
Streptococcus pneumoniae is a leading cause of pneumonia, meningitis, and sepsis. Pneumococci can be divided into >90 serotypes that show differences in the pathogenicity and invasiveness. We tested the hypotheses that the innate immune inflammasome pathway is involved in fighting pneumococcal pneumonia and that some invasive pneumococcal types are not recognized by this pathway. We show that human and murine mononuclear cells responded to S. pneumoniae expressing hemolytic pneumolysin by producing IL-1β. This IL-1β production depended on the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. Some serotype 1, serotype 8, and serotype 7F bacteria, which have previously been associated with increased invasiveness and with production of toxins with reduced hemolytic activity, or bacterial mutants lacking pneumolysin did not stimulate notable IL-1β production. We further found that NLRP3 was beneficial for mice during pneumonia caused by pneumococci expressing hemolytic pneumolysin and was involved in cytokine production and maintenance of the pulmonary microvascular barrier. Overall, the inflammasome pathway is protective in pneumonia caused by pneumococci expressing hemolytic toxin but is not activated by clinically important pneumococcal sequence types causing invasive disease. The study indicates that a virulence factor polymorphism may substantially affect the recognition of bacteria by the innate immune system.
AuthorsMartin Witzenrath, Florence Pache, Daniel Lorenz, Uwe Koppe, Birgitt Gutbier, Christoph Tabeling, Katrin Reppe, Karolin Meixenberger, Anca Dorhoi, Jiangtao Ma, Ashleigh Holmes, George Trendelenburg, Markus M Heimesaat, Stefan Bereswill, Mark van der Linden, Jürg Tschopp, Timothy J Mitchell, Norbert Suttorp, Bastian Opitz
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 187 Issue 1 Pg. 434-40 (Jul 01 2011) ISSN: 1550-6606 [Electronic] United States
PMID21646297 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Proteins
  • Carrier Proteins
  • Inflammasomes
  • Interleukin-18
  • Interleukin-1beta
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
  • Streptolysins
  • TLR2 protein, human
  • TLR4 protein, human
  • TLR9 protein, human
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Toll-Like Receptor 9
  • plY protein, Streptococcus pneumoniae
Topics
  • Animals
  • Bacterial Proteins (biosynthesis, genetics)
  • Bone Marrow Cells (immunology, metabolism, pathology)
  • Carrier Proteins (genetics, metabolism, physiology)
  • Female
  • Genetic Predisposition to Disease
  • Genetic Variation (immunology)
  • Humans
  • Immunity, Innate (genetics)
  • Inflammasomes (metabolism, physiology)
  • Interleukin-18 (physiology)
  • Interleukin-1beta (biosynthesis)
  • Macrophages (immunology, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myeloid Differentiation Factor 88 (deficiency, genetics)
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nod2 Signaling Adaptor Protein (physiology)
  • Pneumonia, Pneumococcal (genetics, immunology, pathology)
  • Signal Transduction (genetics, immunology)
  • Streptolysins (biosynthesis, deficiency, genetics)
  • Toll-Like Receptor 2 (deficiency, genetics)
  • Toll-Like Receptor 4 (deficiency, genetics)
  • Toll-Like Receptor 9 (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: